Packham’s group found that PEITC could target mTORC1 activity in leukemia cells [7,8], and Chung and his co-workers reported that isothiocyanates selectively depleted mutant p53, compared with wild type p53 [9]. The gene discussed is TP53; the disease is leukemia.